- Home
- MNSB vs FENC Comparison
MNSB vs FENC Comparison
Compare MNSB & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- FENC
- Stock Information
- Founded
- MNSB 2003
- FENC 1996
- Country
- MNSB United States
- FENC United States
- Employees
- MNSB N/A
- FENC N/A
- Industry
- MNSB Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNSB Finance
- FENC Health Care
- Exchange
- MNSB Nasdaq
- FENC Nasdaq
- Market Cap
- MNSB 133.8M
- FENC 109.5M
- IPO Year
- MNSB N/A
- FENC 2001
- Fundamental
- Price
- MNSB $18.35
- FENC $4.72
- Analyst Decision
- MNSB
- FENC Strong Buy
- Analyst Count
- MNSB 0
- FENC 2
- Target Price
- MNSB N/A
- FENC $14.00
- AVG Volume (30 Days)
- MNSB 7.9K
- FENC 134.0K
- Earning Date
- MNSB 10-28-2024
- FENC 11-07-2024
- Dividend Yield
- MNSB 2.21%
- FENC N/A
- EPS Growth
- MNSB N/A
- FENC N/A
- EPS
- MNSB 1.21
- FENC N/A
- Revenue
- MNSB $62,730,000.00
- FENC $49,348,000.00
- Revenue This Year
- MNSB N/A
- FENC $116.50
- Revenue Next Year
- MNSB $8.55
- FENC $17.49
- P/E Ratio
- MNSB $15.01
- FENC N/A
- Revenue Growth
- MNSB N/A
- FENC 278.09
- 52 Week Low
- MNSB $14.97
- FENC $3.96
- 52 Week High
- MNSB $25.97
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- MNSB 57.52
- FENC 54.72
- Support Level
- MNSB $17.51
- FENC $3.99
- Resistance Level
- MNSB $18.21
- FENC $4.57
- Average True Range (ATR)
- MNSB 0.39
- FENC 0.34
- MACD
- MNSB 0.07
- FENC 0.04
- Stochastic Oscillator
- MNSB 96.55
- FENC 61.79
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.